Yifen Shi

1.1k total citations · 1 hit paper
33 papers, 888 citations indexed

About

Yifen Shi is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Yifen Shi has authored 33 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Hematology. Recurrent topics in Yifen Shi's work include Lymphoma Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (4 papers) and Acute Myeloid Leukemia Research (4 papers). Yifen Shi is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Cancer-related molecular mechanisms research (4 papers) and Acute Myeloid Leukemia Research (4 papers). Yifen Shi collaborates with scholars based in China, United States and Hong Kong. Yifen Shi's co-authors include He Huang, Qiang He, Li Zhao, Yiwen Li, Juan Jin, Jianguang Gong, Changcan Shi, Bin Liang, Xiang‐Kui Ren and Xiao Yang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Carbohydrate Polymers.

In The Last Decade

Yifen Shi

31 papers receiving 880 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte

2019 289 citations Juan Jin, Yifen Shi et al. Stem Cell Research & Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yifen Shi China	14	429	239	181	149	115	33	888
Mohsen Nikbakht Iran	18	438 1.0×	129 0.5×	187 1.0×	107 0.7×	65 0.6×	78	899
Jie Cheng China	21	467 1.1×	160 0.7×	52 0.3×	148 1.0×	49 0.4×	86	1.2k
Yiming Wang Canada	16	225 0.5×	105 0.4×	436 2.4×	226 1.5×	108 0.9×	38	1.2k
Cristian Turato Italy	21	369 0.9×	221 0.9×	56 0.3×	110 0.7×	185 1.6×	61	987
Cédric Duval United Kingdom	18	158 0.4×	102 0.4×	390 2.2×	200 1.3×	130 1.1×	37	1.1k
Saher Hamed Israel	13	289 0.7×	55 0.2×	141 0.8×	115 0.8×	65 0.6×	19	792
Haifeng Zhao China	19	358 0.8×	253 1.1×	236 1.3×	119 0.8×	63 0.5×	83	1.0k
John Morgan United States	17	592 1.4×	189 0.8×	42 0.2×	327 2.2×	79 0.7×	31	1.2k
Yun Luan China	21	489 1.1×	216 0.9×	95 0.5×	375 2.5×	117 1.0×	59	1.5k
Francesco Agostini Italy	16	272 0.6×	86 0.4×	80 0.4×	109 0.7×	49 0.4×	39	784

Countries citing papers authored by Yifen Shi

Since Specialization

Citations

This map shows the geographic impact of Yifen Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifen Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifen Shi more than expected).

Fields of papers citing papers by Yifen Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifen Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifen Shi. The network helps show where Yifen Shi may publish in the future.

Co-authorship network of co-authors of Yifen Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yifen Shi. A scholar is included among the top collaborators of Yifen Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifen Shi. Yifen Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xia, Rong Yang, Ruochen Wang, et al.. (2024). Causal pathways in Lymphoma: The role of serum metabolites and immune cells determined by Mendelian randomization. International Immunopharmacology. 144. 113593–113593. 1 indexed citations

Yang, Rong, et al.. (2024). Causal pathways in lymphoid leukemia: the gut microbiota, immune cells, and serum metabolites. Frontiers in Immunology. 15. 1437869–1437869. 1 indexed citations

Zhu, Kai, Zhijie Yu, Lili Chen, et al.. (2022). A novel 10-gene ferroptosis-related prognostic signature in acute myeloid leukemia. Frontiers in Oncology. 12. 1023040–1023040. 11 indexed citations

Shi, Liang, et al.. (2022). Multi‐omics data identified TP53 and LRP1B as key regulatory gene related to immune phenotypes via EPCAM in HCC. Cancer Medicine. 11(10). 2145–2158. 5 indexed citations

Zhou, Shujuan, Lan Sun, Yongyong Ma, et al.. (2021). Iron overload adversely effects bone marrow haematogenesis via SIRT-SOD2-mROS in a process ameliorated by curcumin. Cellular & Molecular Biology Letters. 26(1). 2–2. 20 indexed citations

Zhang, Jingcheng, et al.. (2020). Activation-induced cytidine deaminase overexpression in double-hit lymphoma: potential target for novel anticancer therapy. Scientific Reports. 10(1). 14164–14164. 10 indexed citations

Xing, Chongyun, Wanling Xu, Yifen Shi, et al.. (2020). CD9 knockdown suppresses cell proliferation, adhesion, migration and invasion, while promoting apoptosis and the efficacy of chemotherapeutic drugs and imatinib in Ph+ ALL SUP‑B15 cells. Molecular Medicine Reports. 22(4). 2791–2800. 9 indexed citations

Shi, Yifen, Na Wang, Ziyang Huang, et al.. (2020). <p>Normal Absolute Monocyte Count at the Time of Relapse is Associated with Improved Survival After First Salvage Therapy in Adult Patients with Early Relapsed B-Lineage Acute Lymphoblastic Leukemia</p>. Cancer Management and Research. Volume 12. 7097–7105. 1 indexed citations

Yang, Xiao, Wen Liu, Guanghui Xi, et al.. (2019). Fabricating antimicrobial peptide-immobilized starch sponges for hemorrhage control and antibacterial treatment. Carbohydrate Polymers. 222. 115012–115012. 89 indexed citations

10.

Jin, Juan, Yifen Shi, Jianguang Gong, et al.. (2019). Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Research & Therapy. 10(1). 95–95. 289 indexed citations breakdown →

11.

Sun, Lan, Na Wang, Yi Chen, et al.. (2019). Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen. Biology of Blood and Marrow Transplantation. 25(8). 1592–1596. 16 indexed citations

12.

Yang, Xiao, Wen Liu, Yifen Shi, et al.. (2019). Peptide-immobilized starch/PEG sponge with rapid shape recovery and dual-function for both uncontrolled and noncompressible hemorrhage. Acta Biomaterialia. 99. 220–235. 89 indexed citations

13.

Han, Yixiang, Yifen Shi, Wanling Xu, et al.. (2018). Benzene induces haematotoxicity by promoting deacetylation and autophagy. Journal of Cellular and Molecular Medicine. 23(2). 1022–1033. 26 indexed citations

14.

Wu, Lili, Chenwei Pan, Xin Wei, et al.. (2018). lncRNA KRAL reverses 5-fluorouracil resistance in hepatocellular carcinoma cells by acting as a ceRNA against miR-141. Cell Communication and Signaling. 16(1). 47–47. 66 indexed citations

15.

Li, Jiaqi, Songfu Jiang, Yi Chen, et al.. (2017). Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of β-catenin signaling. Toxicology in Vitro. 46. 361–369. 20 indexed citations

16.

Zhou, Shujuan, Siqian Wang, Yongyong Ma, et al.. (2016). Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy. Hematology. 21(6). 332–337. 9 indexed citations

17.

Chen, Jingjing, Yi Chen, Jiaqi Li, et al.. (2016). Histone Deacetylase Inhibitors Trichostatin A and MCP30 Relieve Benzene-Induced Hematotoxicity via Restoring Topoisomerase IIα. PLoS ONE. 11(4). e0153330–e0153330. 11 indexed citations

18.

Yin, Lihui, Xiaoqun Zheng, Haiying Li, et al.. (2015). Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm. Leukemia Research. 39(4). 471–478. 20 indexed citations

19.

Chen, Chiqi, Kang Yu, Chongyun Xing, et al.. (2013). Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class Ι histone deacetylases. Carcinogenesis. 34(7). 1442–1449. 57 indexed citations

20.

Kang, Yu, Yifen Shi, Kaiyan Yang, et al.. (2011). Decreased topoisomerase IIα expression and altered histone and regulatory factors of topoisomerase IIα promoter in patients with chronic benzene poisoning. Toxicology Letters. 203(2). 111–117. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact